280 related articles for article (PubMed ID: 22846914)
1. RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer.
Patel RA; Forinash KD; Pireddu R; Sun Y; Sun N; Martin MP; Schönbrunn E; Lawrence NJ; Sebti SM
Cancer Res; 2012 Oct; 72(19):5025-34. PubMed ID: 22846914
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel ROCK inhibitors with anti-migratory and anti-invasive activities.
Patel RA; Liu Y; Wang B; Li R; Sebti SM
Oncogene; 2014 Jan; 33(5):550-5. PubMed ID: 23396364
[TBL] [Abstract][Full Text] [Related]
3. RKI-1447 suppresses colorectal carcinoma cell growth via disrupting cellular bioenergetics and mitochondrial dynamics.
Li L; Chen Q; Yu Y; Chen H; Lu M; Huang Y; Li P; Chang H
J Cell Physiol; 2020 Jan; 235(1):254-266. PubMed ID: 31237697
[TBL] [Abstract][Full Text] [Related]
4. A novel small-molecule MRCK inhibitor blocks cancer cell invasion.
Unbekandt M; Croft DR; Crighton D; Mezna M; McArthur D; McConnell P; Schüttelkopf AW; Belshaw S; Pannifer A; Sime M; Bower J; Drysdale M; Olson MF
Cell Commun Signal; 2014 Oct; 12():54. PubMed ID: 25288205
[TBL] [Abstract][Full Text] [Related]
5. Rho Kinase Inhibition by AT13148 Blocks Pancreatic Ductal Adenocarcinoma Invasion and Tumor Growth.
Rath N; Munro J; Cutiongco MF; Jagiełło A; Gadegaard N; McGarry L; Unbekandt M; Michalopoulou E; Kamphorst JJ; Sumpton D; Mackay G; Vennin C; Pajic M; Timpson P; Olson MF
Cancer Res; 2018 Jun; 78(12):3321-3336. PubMed ID: 29669760
[TBL] [Abstract][Full Text] [Related]
6. RKI-1447, a Rho kinase inhibitor, causes ocular hypotension, actin stress fiber disruption, and increased phagocytosis.
Dang Y; Wang C; Shah P; Waxman S; Loewen RT; Loewen NA
Graefes Arch Clin Exp Ophthalmol; 2019 Jan; 257(1):101-109. PubMed ID: 30456419
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a novel ROCK2 inhibitor with anti-migration effects via docking and high-content drug screening.
Chong CM; Kou MT; Pan P; Zhou H; Ai N; Li C; Zhong HJ; Leung CH; Hou T; Lee SM
Mol Biosyst; 2016 Aug; 12(9):2713-21. PubMed ID: 27354305
[TBL] [Abstract][Full Text] [Related]
8. 7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel ROCK inhibitor blocks cytoskeleton function and cell migration.
Tsai CC; Liu HF; Hsu KC; Yang JM; Chen C; Liu KK; Hsu TS; Chao JI
Biochem Pharmacol; 2011 Apr; 81(7):856-65. PubMed ID: 21276421
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Rho-kinase inhibitors by docking-based virtual screening.
Shen M; Yu H; Li Y; Li P; Pan P; Zhou S; Zhang L; Li S; Lee SM; Hou T
Mol Biosyst; 2013 Jun; 9(6):1511-21. PubMed ID: 23549429
[TBL] [Abstract][Full Text] [Related]
10. Curcumin inhibits LPA-induced invasion by attenuating RhoA/ROCK/MMPs pathway in MCF7 breast cancer cells.
Sun K; Duan X; Cai H; Liu X; Yang Y; Li M; Zhang X; Wang J
Clin Exp Med; 2016 Feb; 16(1):37-47. PubMed ID: 25596714
[TBL] [Abstract][Full Text] [Related]
11. Potently inhibiting cancer cell migration with novel 3H-pyrazolo[4,3-f]quinoline boronic acid ROCK inhibitors.
Dayal N; Mikek CG; Hernandez D; Naclerio GA; Yin Chu EF; Carter-Cooper BA; Lapidus RG; Sintim HO
Eur J Med Chem; 2019 Oct; 180():449-456. PubMed ID: 31330446
[TBL] [Abstract][Full Text] [Related]
12. Design and development of novel fasudil derivatives as potent antibreast cancer agent that improves intestinal flora and intestinal barrier function in rats.
Liang J; Tang M; Wang L; Huang R; Fu A; Zhou J
Chem Biol Drug Des; 2021 Dec; 98(6):1065-1078. PubMed ID: 34587363
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of Rho kinase (ROCK) signaling revert the malignant phenotype of breast cancer cells in 3D context.
Matsubara M; Bissell MJ
Oncotarget; 2016 May; 7(22):31602-22. PubMed ID: 27203208
[TBL] [Abstract][Full Text] [Related]
14. Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho/Rho-associated coiled-coil-containing protein kinase pathway.
Kidera Y; Tsubaki M; Yamazoe Y; Shoji K; Nakamura H; Ogaki M; Satou T; Itoh T; Isozaki M; Kaneko J; Tanimori Y; Yanae M; Nishida S
J Exp Clin Cancer Res; 2010 Sep; 29(1):127. PubMed ID: 20843370
[TBL] [Abstract][Full Text] [Related]
15. The Effects of RKI-1447 in a Mouse Model of Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet and in HepG2 Human Hepatocellular Carcinoma Cells Treated with Oleic Acid.
Wang J; Jiang W
Med Sci Monit; 2020 Feb; 26():e919220. PubMed ID: 32026851
[TBL] [Abstract][Full Text] [Related]
16. ROCK-regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration.
Ortíz-López L; Morales-Mulia S; Ramírez-Rodríguez G; Benítez-King G
J Pineal Res; 2009 Jan; 46(1):15-21. PubMed ID: 18482340
[TBL] [Abstract][Full Text] [Related]
17. ROCK1 and ROCK2 are required for non-small cell lung cancer anchorage-independent growth and invasion.
Vigil D; Kim TY; Plachco A; Garton AJ; Castaldo L; Pachter JA; Dong H; Chen X; Tokar B; Campbell SL; Der CJ
Cancer Res; 2012 Oct; 72(20):5338-47. PubMed ID: 22942252
[TBL] [Abstract][Full Text] [Related]
18. Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
Kang CG; Im E; Lee HJ; Lee EO
Bioorg Med Chem Lett; 2017 May; 27(9):1914-1918. PubMed ID: 28359791
[TBL] [Abstract][Full Text] [Related]
19. Fragment-based and structure-guided discovery and optimization of Rho kinase inhibitors.
Li R; Martin MP; Liu Y; Wang B; Patel RA; Zhu JY; Sun N; Pireddu R; Lawrence NJ; Li J; Haura EB; Sung SS; Guida WC; Schonbrunn E; Sebti SM
J Med Chem; 2012 Mar; 55(5):2474-8. PubMed ID: 22272748
[TBL] [Abstract][Full Text] [Related]
20. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
